Candel Therapeutics, Inc. (CADL)
USD 6.53
(-1.06%)
USD 6.53
(-1.06%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -34.24 Million | -31.41 Million | -22.21 Million | -9.07 Million | -5.17 Million |
| Net Income | -37.93 Million | -18.79 Million | -36.12 Million | -17.68 Million | -8.24 Million |
| Depreciation & Amortization | 1.2 Million | 778 Thousand | 232 Thousand | 91 Thousand | 43 Thousand |
| Deferred income taxes | -45 Thousand | - | 11.51 Million | 4.6 Million | - |
| Stock-based compensation | 3.09 Million | 2.3 Million | 2.96 Million | 2.1 Million | 400 Thousand |
| Change in working capital | -525 Thousand | 71 Thousand | -876 Thousand | 1.77 Million | 513 Thousand |
| Other non-cash items | -26 Thousand | -15.78 Million | 76 Thousand | 32 Thousand | 2.1 Million |
| Investing Cash Flow | -280 Thousand | -1.29 Million | -1.83 Million | 38.45 Million | -35.74 Million |
| Investments in PPE | -457 Thousand | -1.29 Million | -1.83 Million | -1.47 Million | -159 Thousand |
| Acquisitions | 177 Thousand | - | - | -39.93 Million | -846 Thousand |
| Investment purchases | - | - | - | -6000.00 | -39.1 Million |
| Sales/Maturities of investments | - | - | - | 39.93 Million | 4.37 Million |
| Other Investing Activities | 177 Thousand | - | - | 39.93 Million | -34.73 Million |
| Financing Cash Flow | -121 Thousand | 19.97 Million | 71.8 Million | 490 Thousand | 21.97 Million |
| Debt repayment | - | -19.91 Million | - | -460 Thousand | -522 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -121 Thousand | - | - | - | - |
| Common Stock Issuance | - | 64 Thousand | 71.33 Million | 30 Thousand | 22.5 Million |
| Other Financing Activities | -121 Thousand | 39.82 Million | 465 Thousand | 920 Thousand | 21.97 Million |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | 45 Thousand | -1.21 Million | 669 Thousand | 289 Thousand | 13 Thousand |
| Inventory | - | - | - | - | - |
| Other working capital | -570 Thousand | 1.28 Million | -1.54 Million | 1.48 Million | 500 Thousand |
| Cash at beginning of period | 70.05 Million | 83.06 Million | 35.31 Million | 5.44 Million | 24.38 Million |
| Cash at end of period | 35.41 Million | 70.32 Million | 83.06 Million | 35.31 Million | 5.44 Million |
| Capital Expenditure | -457 Thousand | -1.29 Million | -1.83 Million | -1.47 Million | -159 Thousand |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -34.64 Million | -12.74 Million | 47.74 Million | 29.87 Million | -18.93 Million |
| Free Cash Flow | -34.7 Million | -32.71 Million | -24.05 Million | -10.54 Million | -5.33 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -22.23 Million | -8.22 Million | -37.93 Million | -11.09 Million | -8.43 Million | -9.61 Million |
| Depreciation & Amortization | 249 Thousand | 251 Thousand | 1.2 Million | 312 Thousand | 245 Thousand | 236 Thousand |
| Deferred income taxes | - | - | -45 Thousand | -1.39 Million | -416 Thousand | -144 Thousand |
| Stock-based compensation | 1.84 Million | 1.04 Million | 3.09 Million | 939 Thousand | 686 Thousand | 733 Thousand |
| Change in working capital | 441 Thousand | -1.68 Million | -525 Thousand | 1.59 Million | -1.05 Million | 1.43 Million |
| Other non-cash items | 15.88 Million | 1.66 Million | -26 Thousand | 2.21 Million | 170 Thousand | 163 Thousand |
| Investing Cash Flow | -6000.00 | -7000.00 | -280 Thousand | -27 Thousand | -103 Thousand | -169 Thousand |
| Investments in PPE | -6000.00 | -7000.00 | -457 Thousand | -47 Thousand | -103 Thousand | -169 Thousand |
| Acquisitions | - | - | 177 Thousand | 20 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 177 Thousand | 20 Thousand | - | - |
| Financing Cash Flow | 1.94 Million | -1.25 Million | -121 Thousand | -121 Thousand | - | - |
| Debt repayment | -2.5 Million | -1.66 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -121 Thousand | -121 Thousand | - | - |
| Common Stock Issuance | 4.44 Million | 412 Thousand | - | - | - | - |
| Other Financing Activities | 4445.00 | -1.44 Million | -121 Thousand | -121 Thousand | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -39 Thousand | 50 Thousand | 45 Thousand | 172 Thousand | -214 Thousand | -62 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 480 Thousand | -1.73 Million | -570 Thousand | 1.42 Million | -844 Thousand | 1.49 Million |
| Cash at beginning of period | 25.71 Million | 35.41 Million | 70.05 Million | 42.98 Million | 52.16 Million | 59.52 Million |
| Cash at end of period | 21.45 Million | 25.71 Million | 35.41 Million | 35.41 Million | 43.24 Million | 52.16 Million |
| Capital Expenditure | -6000.00 | -7000.00 | -457 Thousand | -47 Thousand | -103 Thousand | -169 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -4.25 Million | -9.7 Million | -34.64 Million | -7.57 Million | -8.91 Million | -7.36 Million |
| Free Cash Flow | -6.2 Million | -8.44 Million | -34.7 Million | -7.46 Million | -8.91 Million | -7.36 Million |
300898
CULT
3321
FLOWS
CCCS
OLPX